Ghorbani M, Namazi S, Dehghani M, Razi F, et al. Gene polymorphisms of TACR1 serve as the potential pharmacogenetic predictors of response to the neurokinin-1 receptor antagonist-based antiemetic regimens: a candidate-gene association study in breast cancer patients. Cancer Chemother Pharmacol 2024 Apr 27. doi: 10.1007/s00280-024-04661.
PMID: 38678150